ShoeWow, Specialist in Footwear for Plantar Fasciitis, Finds That Hope is on the

Horizon for Heel Pain Sufferers

A drug called AmnioFix has reached advanced trials, and could offer symptom relief, and even
repair the damage done by Plantar Fasciitis.

Marietta, GA, August 22, 2017 --(PR.com)-- Approximately 1 in 10 Americans will suffer from plantar
fasciitis during their lives, making it the most common cause of foot pain and heel pain. The only options
for treatment are pain relief for the symptoms, or corrective surgery that doesn't offer a lifetime cure. A
company called Mimedx has brought hope to the millions who suffer this condition globally; their
AmnioFix drug has passed phase 2B of clinical trials, and is only step away from being made readily
available.

The Plantar Fascia is the tissue that runs underneath the foot. Plantar Fasciitis is the thickening of this
wall, and can be caused by a series of minor injuries. It is sometimes referred to as jogger's heel, because
it is most common in long distance runners. However, professionals like nurses and policemen, who
spend a lot of their time on their feet, are also more prone to this condition.

Symptoms include inflammation of the foot, and a sharp, stabbing pain in the heel. These symptoms are
most likely to occur in the morning and also following exercise.

Current treatment for this condition typically means treating the pain and other symptoms.
Anti-inflammatory drugs and pain killers are commonly used. Splints may also be worn overnight, which
relieve some of the pressure on the plantar and the rest of the heel. Surgery may be considered, if a
patient's pain is acute or they have suffered the condition for many years, but this doesn't offer a
long-term solution either. The problem will usually resurface after years or even months.

AmnioFix uses cells that are removed from the amniotic membrane that surrounds a child. This
membrane is usually discarded after birth, and the collection of the tissue is ethical, pain free, and does
not cause complications. It is collected from willing donors that give birth using caesarean section.

Matt Jackson, of ShoeWow.com, who specialises in providing information on plantar fasciitis shoes and
footwear for other common health complaints, welcomed the possibility of a more effective long-term
solution to what is a common foot complaint. Sufferers have very few options for managing pain, and no
options for the long-term relief of the problem. Drugs can relieve the pain, while choosing the right shoe
and combining this with a supportive shoe insert can help relieve a lot of the pressure when playing
sports, walking, or standing around all day, but, if the final trials are successful, AmnioFix could bring
lifelong relief for a very painful condition.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
ShoeWow
Matt Jackson
(+44)7450914222
Contact via Email
http://shoewow.com/
Prefer to be contacted by email.

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/727409

Page 2/2
PR.com Press Release Distribution Terms of Use